Arsene Mekinian Announces New Expert Clinic for Refractory Hemato-Immunologic Diseases
Arsene Mekinian, Professor of Medicine at Sorbonne University, President of Santé Arménie, posted on LinkedIn:
”Dear Brothers, Dear Sisters,
We would like to inform you of the creation of a dedicated specialized consultation within the MINHEMON group, a national FAI2R reference center dedicated to the management of complex hematoimmunological pathologies in person or remotely by video.
This consultation has been specifically set up to accommodate patients with atypical, severe or refractory pictures, particularly when the question arises of an immunological mechanism associated with clonal haemopathy or acquired somatic mutations.
Main indications (non-exhaustive list)
• Myelodysplastic syndromes (MDS/CMML) with inflammatory or autoimmune manifestations
• Chronic lymphocytic leukemia (CLL) complicated by immune dysregulation
• Lymphomas associated with systemic inflammatory or autoimmune manifestations
• Suspected or confirmed VEXAS syndrome
• Severe or refractory systemic autoimmune diseases, especially when hematopoietic clonality or somatic mutation is suspected (UBA1, TET2, DNMT3A, ASXL1, etc.)
Objectives of the dedicated consultation
• Integrated clinical, hematological, immunological and genetic evaluation
• Targeted discussion of specialist examinations (cytometry, myelogram, targeted or expanded NGS)
• Differential diagnosis of borderline or unclassifiable shapes
• Proposal of personalized therapeutic strategies, including innovative options when relevant
Requests for guidance can be sent with:
• a structured clinical summary,
• recent biological assessments,
• the haematological and genetic reports available here will be provided by Dr Vincent Jachiet, Dr Jerome Hadjadj, and Dr Arsène Mekinian”
Stay updated with Hemostasis Today.
-
Aug 23, 2026, 17:51Gurpreet Kaurr: A Proud Milestone in Haematology and Oncology
-
Aug 23, 2026, 17:33Kathrine Kaspersen: How Voluntary Plasma Donors Helped Transform Denmark’s Plasma Supply
-
Aug 23, 2026, 16:51Sthanu Subramanian: Empagliflozin and a Rise in Hematocrit
-
Aug 23, 2026, 16:50Lale Tokgözoğlu: New PCSK9i Research Published in the European Heart Journal
-
Aug 23, 2026, 16:44Eric Gehrie: Your 2026 Guide to the Essentials of Transfusion Medicine
-
Aug 23, 2026, 16:35Thomas Dayspring: The Overlooked Pathway in Cholesterol Homeostasis
-
Aug 23, 2026, 16:28Evan Mapelu: The People Who Make Cancer Care Meaningful
-
Aug 23, 2026, 16:09Felice Gragnano: New Publication on Aspirin Discontinuation After PCI for Acute Coronary Syndromes
-
Aug 23, 2026, 16:06Mostafa Faisal: Donor Type and Long-Term Quality of Life After HCT for Severe Aplastic Anemia